Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/anr3.12060 http://scihub22266oqcxt.onion/10.1002/anr3.12060 33251512!7678888!33251512     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Anaesth+Rep 2020 ; 8 (2): 98-100 Nephropedia Template TP {{tp|p=33251512|t=2020. Rocuronium priming for tracheal intubation in COVID-19 patients |pdf=|usr=}}{{33251512}} gab.com Text Rocuronium priming for tracheal intubation in COVID-19 patients JO: Anaesth Rep http://www.kidney.de/pget.php?&tw=1&pmid=33251512 #FOAvip Priming doses of non-depolarising neuromuscular blocking drugs given before administration of anaesthetic agents have been used to hasten the onset of neuromuscular blockade. In the settings of coronavirus disease 2019 (COVID-19), this could be used to reduce the apnoeic, and potentially aerosol-generating, window. To our knowledge, we report the first cases of tracheal intubation with rocuronium for COVID-19 using the priming principle. Both patients needed their tracheas intubated for severe hypoxia using a rapid sequence induction technique with a priming dose of rocuronium. Despite adequate pre-oxygenation a sudden, unexpected fall in arterial oxygen saturations was observed in both patients after administration of a priming dose of 2 mg of rocuronium. Clinicians should consider this possible risk associated with priming doses of neuromuscular blocking drugs in the management of patients with respiratory failure due to COVID-19. Twit Text FOAVip Rocuronium priming for tracheal intubation in COVID-19 patients ????Anaesth Rep http://www.kidney.de/pget.php?&tw=1&pmid=33251512 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33251512 #FOAvip English Wikipedia <ref>{{Cite pmid|33251512}}</ref> Rocuronium priming for tracheal intubation in COVID-19 patients #MMPMID33251512 Hoshijima H; Nagasaka H; Ozaki M; Komiyama K; Mieda T; Nakamura C; Doi K Anaesth Rep 2020[Jul]; 8 (2): 98-100 PMID33251512show ga Priming doses of non-depolarising neuromuscular blocking drugs given before administration of anaesthetic agents have been used to hasten the onset of neuromuscular blockade. In the settings of coronavirus disease 2019 (COVID-19), this could be used to reduce the apnoeic, and potentially aerosol-generating, window. To our knowledge, we report the first cases of tracheal intubation with rocuronium for COVID-19 using the priming principle. Both patients needed their tracheas intubated for severe hypoxia using a rapid sequence induction technique with a priming dose of rocuronium. Despite adequate pre-oxygenation a sudden, unexpected fall in arterial oxygen saturations was observed in both patients after administration of a priming dose of 2 mg of rocuronium. Clinicians should consider this possible risk associated with priming doses of neuromuscular blocking drugs in the management of patients with respiratory failure due to COVID-19. äRocuronium priming for tracheal intubation in COVID-19 patients (epmc).pdf DeepDyve Pubget Overpricing